News from the healthcare data industry
WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences solutions, recognizes the vital importance of the Voice of the Patient across the entire product lifecycle. Trinity’s patient focus has evolved over 25 years, with the formation of the Patient Centricity Center of Excellence (COE) in 2019 to recognize…
SOLANA BEACH, Calif. and CHICAGO, Feb. 02, 2022 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company primarily focused on treatments for gastrointestinal (GI) diseases, and EVERSANA Life Science Services, LLC, an independent provider of global commercial services to the life science industry, today announced the extension…
HAYWARD, Calif., Feb. 1, 2022 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication of real-world data in patients undergoing awake plastic surgery showing a rapid recovery time and minimal side effects…
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges…
CHICAGO, Feb. 01, 2022 (GLOBE NEWSWIRE) — Q-Centrix, the largest exclusive provider of clinical data management solutions to health systems, today announced a partnership with Datavant, the leader in helping organizations securely connect health data. The partnership will enhance Q-Centrix’s high-fidelity clinical data management capabilities with Datavant’s connectivity technology and real-world data…
During his talk at the recent J.P. Morgan Healthcare Conference, Mayo Clinic CEO Gianrico Farrugia laid out a sweeping vision for technology transformation, driven largely by private sector upstarts that have partnered with the health system. Every few minutes, he punctuated references to this cadre of companies with a disclosure:…
Scott brings a unique combination of financial and clinical fused with growth experience to Saama New CFO appointment follows October announcement of $430M growth investment February 02, 2022 08:00 AM Eastern Standard Time CAMPBELL, Calif.–(BUSINESS WIRE)–Saama Technologies, Inc. (“Saama”) today announced that Scott Rogers, 17-year industry veteran, has been appointed as…
The Chan Zuckerberg Initiative’s Rare as One Network will gain access to Komodo’s Healthcare Map to advance research and better understand care gapsJanuary 31, 2022 09:11 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Komodo Health today announced it will be enabling rare disease patient advocacy organizations in the Chan Zuckerberg Initiative’s…
January 27, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics and Providence Health Plan today announced a collaboration to conduct a Phase 3 study of Cognito’s breakthrough, non-invasive disease-modifying therapy for patients with Mild Cognitive Impairment (MCI). The Phase 3 real-world evidence study will evaluate the safety, efficacy,…
Published on 01/27/2022 By Matthew Franklin, Dan Howdon, Suzanne Mason, Tony Stone, Monica Jones The use of the terms “real-world data” and “real-world evidence” in the context of health decision-making has grown substantially in the last 20 years, although unified and consistent definitions of these terms remain elusive. Often referred to as ‘administrative,’ ‘observational,’ ‘routine,’ ‘large,’…